Novogene Co., Ltd., together with its subsidiaries, provides genomic services and solutions in Mainland China, Hong Kong, Macau, Taiwan, and internationally. Th...
Statement on Novogene Erroneously Listed on 1260H List
Novogene (688315): Won the procurement project of Shenzhen Bay Laboratory, with a bid amount of 5 million yuan
Novogene Investment establishes a genetic technology company
Novogene released its performance for the first three quarters, with a net profit attributable to the parent company of 113 million yuan, a year-on-year decrease of 16.05%
Novogene: In the first three quarters of 2025, an asset impairment provision of 24.5321 million yuan was made
Novogene released its semi-annual performance report, with a net profit attributable to the parent company of 78.73 million yuan, a year-on-year increase of 1.03%